Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial

[1] Stupp R(2005)Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Eng J Med 352 987-996

[2] Mason WP(2009)Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial Lancet Oncol 10 459-466

[3] van den Bent MJ(2010)Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study J Neurooncol 99 261-272

[4] Weller M(2008)Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme Clin Cancer Res 14 3098-3104

[5] Fisher B(2009)An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme Mol Cancer Ther 8 2773-2779

[6] Taphoom MJ(2008)Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients Cancer Res 68 5955-5964

[7] Belanger K(2010)Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours Pediatr Blood Cancer 54 519-525

[8] Brandes AA(2004)Transient local response and persistent tumor control of recurrent malignant glioma treated with combination therapy including dendritic cell therapy J Neurosurg (pediatrics) 100 492-497

[9] Marosi C(2009)Immunotherapy of diffuse gliomas: biological background, current status and future developments Brain Pathol 19 674-693

[10] Bogdahn U(2005)Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment Clin Cancer Res 11 5515-5525

[1] Stupp R(2005)Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Eng J Med 352 987-996

[2] Mason WP(2009)Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial Lancet Oncol 10 459-466

[3] van den Bent MJ(2010)Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study J Neurooncol 99 261-272

[4] Weller M(2008)Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme Clin Cancer Res 14 3098-3104

[5] Fisher B(2009)An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme Mol Cancer Ther 8 2773-2779

[6] Taphoom MJ(2008)Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients Cancer Res 68 5955-5964

[7] Belanger K(2010)Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours Pediatr Blood Cancer 54 519-525

[8] Brandes AA(2004)Transient local response and persistent tumor control of recurrent malignant glioma treated with combination therapy including dendritic cell therapy J Neurosurg (pediatrics) 100 492-497

[9] Marosi C(2009)Immunotherapy of diffuse gliomas: biological background, current status and future developments Brain Pathol 19 674-693

[10] Bogdahn U(2005)Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment Clin Cancer Res 11 5515-5525